Insilico's AI-designed drug Rentosertib reverses biological age by 3-4 years in 12-week trial
AllThingsApx · x · 2026-09-07
Insilico Medicine reports that Rentosertib, an AI-designed drug candidate originally developed for a rare lung condition, appears to reverse biological aging in humans.
- After 12 weeks, all 6 aging clocks run by 6 independent groups read subjects 3-4 years younger
- It is claimed to be the first clinical demonstration of biological age reversal by an AI-designed drug
- Insilico invites users to run their own experiments with its SOTA models
Related event: AI-Designed IPF Drug Rentosertib Shows Biological Age Reversal in Trial(18 posts)→
More from Research
- DeepMind paper: LLMs can't sample randomly on their own, only convert given seeds — rohanpaul_ai · 2026-10-27
- DeepMind paper: LLMs can't sample randomly on their own — pass random numbers from code instead — rohanpaul_ai · 2026-10-27
- World Model Assigns Weight and Friction to Objects, Then Simulates with a Physics Engine — jonstephens85 · 2026-10-27
- Token Collapse: Study Finds Graph Soft Prompting Tokens in LLMs Fail to Encode Structure — Sapienza · 2026-10-27
- Mathathon 2.0 launches with Terence Tao's SAIR, $1.5M in compute for teams — _sathvikr · 2026-10-27
- The 'sweet lesson' is real: two kinds of ML problems need opposite strategies — mike64_t · 2026-10-27